|
1
|
Haslehurst AM, Koti M, Dharsee M, Nuin P,
Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, Davey S,
Squire J, Park PC and Feilotter H: EMT transcription factors snail
and slug directly contribute to cisplatin resistance in ovarian
cancer. BMC Cancer. 12:912012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holschneider CH and Berek JS: Ovarian
cancer: Epidemiology, biology, and prognostic factors. Sem Surg
Oncol. 19:3–10. 2000. View Article : Google Scholar
|
|
3
|
Elloul S, Vaksman O, Stavnes HT, Trope CG,
Davidson B and Reich R: Mesenchymal-to-epithelial transition
determinants as characteristics of ovarian carcinoma effusions.
Clin Exp Metastasis. 27:161–172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yuan H, Kajiyama H, Ito S, Yoshikawa N,
Hyodo T, Asano E, Hasegawa H, Maeda M, Shibata K, Hamaguchi M,
Kikkawa F and Senga T: Alx1 induces snail expression to promote
epithelial-to-mesenchymal transition and invasion of ovarian cancer
cells. Cancer Res. 73:1581–1590. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rosano L, Cianfrocca R, Spinella F, Di
Castro V, Nicotra MR, Lucidi A, Ferrandina G, Natali PG and Bagnato
A: Acquisition of chemoresistance and EMT phenotype is linked with
activation of the endothelin A receptor pathway in ovarian
carcinoma cells. Clin Cancer Res. 17:2350–2360. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qi S, Xin Y, Guo Y, Diao Y, Kou X, Luo L
and Yin Z: Ampelopsin reduces endotoxic inflammation via repressing
ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int
Immunopharmacol. 12:278–287. 2012. View Article : Google Scholar
|
|
7
|
Xie XF, Wang JW, Zhang HP, Li QX and Chen
BY: Chemical composition, antimicrobial and antioxidant activities
of essential oil from Ampelopsis megalophylla. Natural Prod Res.
28:853–860. 2014. View Article : Google Scholar
|
|
8
|
Zhou Y, Shu F, Liang X, Chang H, Shi L,
Peng X, Zhu J and Mi M: Ampelopsin induces cell growth inhibition
and apoptosis in breast cancer cells through ROS generation and
endoplasmic reticulum stress pathway. PLoS One. 9:e890212014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ni F, Gong Y, Li L, Abdolmaleky HM and
Zhou JR: Flavonoid ampelopsin inhibits the growth and metastasis of
prostate cancer in vitro and in mice. PLoS One. 7:e388022012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Luo GQ, Zeng S and Liu DY: Inhibitory
effects of ampelopsin on angiogenesis. Zhong Yao Cai. 29:146–150.
2006.(In Chinese). PubMed/NCBI
|
|
11
|
Wilson AJ, Barham W, Saskowski J,
Tikhomirov O, Chen L, Lee HJ, Yull F and Khabele D: Tracking NF-κB
activity in tumor cells during ovarian cancer progression in a
syngeneic mouse model. J Ovarian Res. 6:632013. View Article : Google Scholar
|
|
12
|
Nishio H, Yaguchi T, Sugiyama J, Sumimoto
H, Umezawa K, Iwata T, Susumu N, Fujii T, Kawamura N, Kobayashi A,
Park J, Aoki D and Kawakami Y: Immunosuppression through
constitutively activated NF-κB signalling in human ovarian cancer
and its reversal by an NF-κB inhibitor. Br J Cancer. 110:2965–2974.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cianfrocca R, Tocci P, Semprucci E,
Spinella F, Di Castro V, Bagnato A and Rosano L: β-arrestin 1 is
required for endothelin-1-induced NF-κB activation in ovarian
cancer cells. Life Sci. Feb 12–2014.(Epub ahead of print).
View Article : Google Scholar
|
|
14
|
Maier HJ, Schmidt-Strassburger U, Huber
MA, Wiedemann EM, Beug H and Wirth T: NF-kappaB promotes
epithelial-mesenchymal transition, migration and invasion of
pancreatic carcinoma cells. Cancer Lett. 295:214–228. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu ZY, Dong R, Li D, Li WB, Xu FQ, Geng Y
and Zhang YS: SNAI1 overexpression induces stemness and promotes
ovarian cancer cell invasion and metastasis. Oncol Rep.
27:1587–1591. 2012.PubMed/NCBI
|
|
16
|
Parikh A, Lee C, Peronne J, Marchini S,
Baccarini A, Kolev V, Romualdi C, Fruscio R, Shah H, Wang F,
Mullokandov G, Fishman D, D’Incalci M, Rahaman J, Kalir T, Redline
RW, Brown BD, Narla G and DiFeo A: MicroRNA-181a has a critical
role in ovarian cancer progression through the regulation of the
epithelial-mesenchymal transition. Nat Commun. 5:29772014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Adham SA, Al Harrasi I, Al Haddabi I, Al
Rashdi A, Al Sinawi S, Al Maniri A, Ba-Omar T and Coomber BL:
Immunohistological insight into the correlation between
neuropilin-1 and epithelial mesenchymal transition markers in
epithelial ovarian cancer. J Histochem Cytochem. 62:619–631. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim MK, Kim MA, Kim H, Kim YB and Song YS:
Expression profiles of epithelial-mesenchymal transition-associated
proteins in epithelial ovarian carcinoma. Biomed Res Int.
2014:4957542014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marchini S, Fruscio R, Clivio L, Beltrame
L, Porcu L, Fuso Nerini I, Cavalieri D, Chiorino G, Cattoretti G,
Mangioni C, Milani R, Torri V, Romualdi C, Zambelli A, Romano M,
Signorelli M, di Giandomenico S and D’Incalci M: Resistance to
platinum-based chemotherapy is associated with epithelial to
mesenchymal transition in epithelial ovarian cancer. Eur J Cancer.
49:520–530. 2013. View Article : Google Scholar
|
|
20
|
Du F, Wu X, Liu Y, Wang T, Qi X, Mao Y,
Jiang L, Zhu Y, Chen Y, Zhu R, Han X, Jin J, Ma X and Hua D:
Acquisition of paclitaxel resistance via PI3K-dependent
epithelial-mesenchymal transition in A2780 human ovarian cancer
cells. Oncol Rep. 30:1113–1118. 2013.PubMed/NCBI
|
|
21
|
Uno M, Saitoh Y, Mochida K, Tsuruyama E,
Kiyono T, Imoto I, Inazawa J, Yuasa Y, Kubota T and Yamaoka S:
NF-κB inducing kinase, a central signaling component of the
non-canonical pathway of NF-κB, contributes to ovarian cancer
progression. PLoS One. 9:e883472014. View Article : Google Scholar
|
|
22
|
Block MS, Charbonneau B, Vierkant RA,
Fogarty Z, Bamlet WR, Pharoah PD, Rossing MA, Cramer D, Pearce CL,
Schildkraut J, Menon U, Kjaer SK, Levine DA, Gronwald J, Culver HA,
Whittemore AS, Karlan BY, Lambrechts D, Wentzensen N, Kupryjanczyk
J, Chang-Claude J, Bandera EV, Hogdall E, Heitz F, Kaye SB,
Fasching PA, Campbell I, Goodman MT, Pejovic T, Bean YT, Hays LE,
Lurie G, Eccles D, Hein A, Beckmann MW, Ekici AB, Paul J, Brown R,
Flanagan JM, Harter P, du Bois A, Schwaab I, Hogdall CK, Lundvall
L, Olson SH, Orlow I, Paddock LE, Rudolph A, Eilber U,
Dansonka-Mieszkowska A, Rzepecka IK, Ziolkowska-Seta I, Brinton LA,
Yang H, Garcia-Closas M, Despierre E, Lambrechts S, Vergote I,
Walsh CS, Lester J, Sieh W, McGuire V, Rothstein JH, Ziogas A,
Lubinski J, Cybulski C, Menkiszak J, Jensen A, Gayther SA, Ramus
SJ, Gentry-Maharaj A, Berchuck A, Wu AH, Pike MC, Van Den Berg D,
Terry KL, Vitonis AF, Ramirez SM, Rider DN, Knutson KL, Sellers TA,
Phelan CM, Doherty JA, Johnatty SE, deFazio A, Song H, Tyrer J,
Kalli KR, Fridley BL, Cunningham JM and Goode EL: Variation in
NF-κB signaling pathways and survival in invasive epithelial
ovarian cancer. Cancer Epidemiol Biomarkers Prev. 23:1421–1427.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Annunziata CM, Stavnes HT, Kleinberg L,
Berner A, Hernandez LF, Birrer MJ, Steinberg SM, Davidson B and
Kohn EC: Nuclear factor kappaB transcription factors are
coexpressed and convey a poor outcome in ovarian cancer. Cancer.
116:3276–3284. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cichon MA and Radisky DC: ROS-induced
epithelial-mesenchymal transition in mammary epithelial cells is
mediated by NF-κB-dependent activation of Snail. Oncotarget.
5:2827–2838. 2014.PubMed/NCBI
|
|
25
|
Liu L, Salnikov AV, Bauer N,
Aleksandrowicz E, Labsch S, Nwaeburu C, Mattern J, Gladkich J,
Schemmer P, Werner J and Herr I: Triptolide reverses
hypoxia-induced epithelial-mesenchymal transition and stem-like
features in pancreatic cancer by NF-κB downregulation. Int J
Cancer. 134:2489–2503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu L, Mu Y, Sa N, Wang H and Xu W: Tumor
necrosis factor α induces epithelial-mesenchymal transition and
promotes metastasis via NF-κB signaling pathway-mediated twist
expression in hypopharyngeal cancer. Oncol Rep. 31:321–327.
2014.
|
|
27
|
Wang Y, Lin Z, Sun L, Fan S, Huang Z,
Zhang D, Yang Z, Li J and Chen W: Akt/Ezrin Tyr353/NF-κB pathway
regulates EGF-induced EMT and metastasis in tongue squamous cell
carcinoma. Br J Cancer. 110:695–705. 2014. View Article : Google Scholar
|
|
28
|
Deep G, Jain AK, Ramteke A, Ting H,
Vijendra KC, Gangar SC, Agarwal C and Agarwal R: SNAI1 is critical
for the aggressiveness of prostate cancer cells with low
E-cadherin. Mol Cancer. 13:372014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cano A, Perez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tuhkanen H, Soini Y, Kosma VM, Anttila M,
Sironen R, Hamalainen K, Kukkonen L, Virtanen I and Mannermaa A:
Nuclear expression of Snail1 in borderline and malignant epithelial
ovarian tumours is associated with tumour progression. BMC Cancer.
9:2892009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen KC, Chen CY, Lin CR, Yang TY, Chen
TH, Wu LC and Wu CC: Luteolin attenuates TGF-β1-induced
epithelial-mesenchymal transition of lung cancer cells by
interfering in the PI3K/Akt-NF-κB-Snail pathway. Life Sci.
93:924–933. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen Z, Liu M, Liu X, Huang S, Li L, Song
B, Li H, Ren Q, Hu Z, Zhou Y and Qiao L: COX-2 regulates E-cadherin
expression through the NF-κB/Snail signaling pathway in gastric
cancer. Int J Mol Med. 32:93–100. 2013.PubMed/NCBI
|
